Magenta Therapeutics Inc. (MGTA)

AI Score

Unlock

0.70

-0.06 (-7.69%)

At close: Sep 11, 2023, 8:00 PM

Magenta Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-40.99M	-42.48M	-53.19M	-80.9M	-79.31M	-80.3M	-79.83M	-74.69M	-73.62M	-73.75M	-76.16M	-78.7M	-84.27M	-88.54M	-87.86M	-82.97M	-76.26M	-70.32M	-65.01M	-59.96M	-50.2M	-40.52M	-42.22M	-35.73M	-27.56M	-20.54M	-4.81M
Interest Income	8.08M	8.24M	4.96M	2.89M	3.73M	3.36M	2.55M	2.87M	2.92M	2.81M	3.74M	3.77M	2.87M	2.17M	1.23M	1.52M	2.77M	3.45M	3.82M	2.45M	1.33M	746K	381K	236K	102K	n/a	n/a
Pretax Income	-67.39M	-68.69M	-82.68M	-76.46M	-75.58M	-76.94M	-76.6M	-71.14M	-70.01M	-70.26M	-72.41M	-74.94M	-80M	-83.32M	-81.95M	-76.77M	-70.21M	-65.24M	-61.19M	-57.52M	-48.87M	-39.77M	-41.84M	-35.49M	-27.45M	-20.54M	-4.81M
Net Income	-67.32M	-69.81M	-83.8M	-80.54M	-76.77M	-76.94M	-76.6M	-71.14M	-70.01M	-70.26M	-72.41M	-74.94M	-80M	-83.32M	-81.95M	-76.77M	-70.21M	-65.24M	-61.19M	-57.52M	-48.87M	-39.77M	-41.84M	-35.49M	-27.45M	-20.54M	-4.81M
Selling & General & Admin	26.11M	23.44M	24.61M	25.76M	26.84M	28.24M	28.24M	27.93M	27.71M	26.85M	27.77M	28.09M	27.2M	26.73M	25.23M	23.76M	23.38M	22.54M	20.98M	18.62M	15.7M	12.22M	9.8M	7.83M	5.21M	3.4M	1.49M
Research & Development	31.88M	35.13M	46.59M	55.14M	52.47M	52.06M	51.59M	46.77M	45.91M	46.9M	48.38M	50.62M	57.07M	61.81M	62.63M	59.21M	52.88M	47.78M	44.03M	41.34M	34.5M	28.29M	32.43M	27.9M	22.35M	17.14M	3.32M
Other Expenses	19.92M	19.92M	18M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	58M	58.57M	71.19M	80.9M	79.31M	80.3M	79.83M	74.69M	73.62M	73.75M	76.16M	78.7M	84.27M	88.54M	87.86M	82.97M	76.26M	70.32M	65.01M	59.96M	50.2M	40.52M	42.22M	35.73M	27.56M	20.54M	4.81M
Interest Expense	n/a	1.19M	1.19M	1.19M	1.19M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	58M	58.57M	71.19M	80.9M	79.31M	80.3M	79.83M	74.69M	73.62M	73.75M	76.16M	78.7M	84.27M	88.54M	87.86M	82.97M	76.26M	70.32M	65.01M	59.96M	50.2M	40.52M	42.22M	35.73M	27.56M	20.54M	4.81M
Income Tax Expense	-6.08M	-4.89M	1.34M	4.3M	877K	-313K	-535K	-535K	-495K	-495K	-495K	-495K	-485K	-485K	-485K	-485K	-359K	-359K	-359K	-359K	236K	236K	236K	236K	n/a	n/a	n/a
Shares Outstanding (Basic)	3.91M	3.19M	3.19M	3.12M	3.12M	58.82M	58.8M	58.79M	58.58M	53.71M	48.57M	48.35M	48.26M	39.61M	39.36M	39.07M	38.82M	36.66M	33.42M	33.2M	33M	4.39M	34.37M	21.5M	21.5M	21.5M	21.5M
Shares Outstanding (Diluted)	3.91M	3.19M	3.19M	3.12M	3.12M	58.82M	58.8M	58.79M	58.58M	53.71M	48.57M	48.35M	48.26M	39.61M	39.36M	39.07M	38.82M	36.66M	33.42M	33.2M	33M	4.39M	34.37M	21.5M	21.5M	21.5M	21.5M
EPS (Basic)	-20.4	-22.15	-21.41	-13.59	-6.54	-1.31	-1.34	-1.31	-1.36	-1.43	-1.59	-1.74	-1.95	-2.12	-2.12	-2.05	-1.96	-1.91	-4.54	-4.42	-4.29	-4.12	-1.74	-1.64	-1.27	-0.95	-0.22
EPS (Diluted)	-20.4	-22.15	-21.41	-13.59	-6.54	-1.31	-1.34	-1.31	-1.36	-1.43	-1.59	-1.74	-1.95	-2.12	-2.12	-2.05	-1.96	-1.91	-4.54	-4.42	-4.29	-4.12	-1.74	-1.64	-1.27	-0.95	-0.22
EBITDA	-36.27M	-37.29M	-51.83M	-78.75M	-77.63M	-78.56M	-77.61M	-73.21M	-72.13M	-72.31M	-74.69M	-77.22M	-82.79M	-87.07M	-86.44M	-81.61M	-74.9M	-69.24M	-64.22M	-59.45M	-49.32M	-39.73M	-41.5M	-35.12M	-27.31M	-20.41M	-4.78M
EBIT	-23.06M	-37.94M	-37.94M	-37.94M	-14.87M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	4.68M	5.19M	1.14M	1.93M	1.99M	2.06M	2.76M	2.02M	1.98M	1.94M	1.96M	1.98M	1.97M	1.96M	1.91M	1.84M	1.72M	1.44M	1.15M	875K	645K	554K	490K	376K	247K	129K	33K